UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

: AMLvitabalans-5mg-Tablet-SE-IS-RA - XML Representation

Raw xml | Download



<RegulatedAuthorization xmlns="http://hl7.org/fhir">
  <id value="AMLvitabalans-5mg-Tablet-SE-IS-RA"/>
  <meta>
    <profile
             value="http://unicom-project.eu/fhir/StructureDefinition/PPLRegulatedAuthorization"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: RegulatedAuthorization AMLvitabalans-5mg-Tablet-SE-IS-RA</b></p><a name="AMLvitabalans-5mg-Tablet-SE-IS-RA"> </a><a name="hcAMLvitabalans-5mg-Tablet-SE-IS-RA"> </a><a name="hcAMLvitabalans-5mg-Tablet-SE-IS-RA-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/marketingAuthorizationNumber</code>/43520</p><p><b>subject</b>: <a href="MedicinalProductDefinition-AMLvitabalans-5mg-Tablet-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002026-00043520,http://ema.europa.eu/fhir/eurdId#174; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = • Hypertoni. • Kronisk stabil angina pectoris.  • Vasospastisk (Prinzmetals) angina; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = C08CA01</a></p><p><b>type</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/220000000060 220000000061}">Marketing Authorisation</span></p><p><b>region</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></p><p><b>status</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072049 100000072099}">Valid</span></p><p><b>statusDate</b>: 2011-06-23</p><p><b>holder</b>: <a href="Organization-LOC-100005946.html">Organization Vitabalans Oy</a></p><h3>Cases</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Date[x]</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://ema.europa.eu/fhir/authorisationDateType dateOfFirstAuthorisation}">First Authorisation</span></td><td>2011-06-23</td></tr></table></div>
  </text>
  <identifier>
    <system value="http://ema.europa.eu/fhir/marketingAuthorizationNumber"/>
    <value value="43520"/>
  </identifier>
  <subject>🔗 
    <reference
               value="MedicinalProductDefinition/AMLvitabalans-5mg-Tablet-SE-IS-MPD"/>
  </subject>
  <type>
    <coding>
      <system value="https://spor.ema.europa.eu/v1/lists/220000000060"/>
      <code value="220000000061"/>
      <display value="Marketing Authorisation"/>
    </coding>
  </type>
  <region>
    <coding>
      <system value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
      <code value="100000000535"/>
      <display value="Kingdom of Sweden"/>
    </coding>
  </region>
  <status>
    <coding>
      <system value="https://spor.ema.europa.eu/v1/lists/100000072049"/>
      <code value="100000072099"/>
      <display value="Valid"/>
    </coding>
  </status>
  <statusDate value="2011-06-23"/>
  <holder>🔗 
    <reference value="Organization/LOC-100005946"/>
  </holder>
  <case>
    <type>
      <coding>
        <system value="https://ema.europa.eu/fhir/authorisationDateType"/>
        <code value="dateOfFirstAuthorisation"/>
        <display value="First Authorisation"/>
      </coding>
    </type>
    <dateDateTime value="2011-06-23"/>
  </case>
</RegulatedAuthorization>